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Abstract
African swine fever virus (ASFV), like other complex DNA viruses, deploys a variety of strategies to evade the host’s defence
systems, such as inflammatory and immune responses and cell death. Here, we analyse the modifications in the translational
machinery induced by ASFV. During ASFV infection, eIF4G and eIF4E are phosphorylated (Ser1108 and Ser209, respectively),
whereas 4E-BP1 is hyperphosphorylated at early times post infection and hypophosphorylated after 18 h. Indeed, a potent
increase in eIF4F assembly is observed in ASFV-infected cells, which is prevented by rapamycin treatment. Phosphorylation
of eIF4E, eIF4GI and 4E-BP1 is important to enhance viral protein production, but is not essential for ASFV infection as
observed in rapamycin- or CGP57380-treated cells. Nevertheless, eIF4F components are indispensable for ASFV protein
synthesis and virus spread, since eIF4E or eIF4G depletion in COS-7 or Vero cells strongly prevents accumulation of viral
proteins and decreases virus titre. In addition, eIF4F is not only activated but also redistributed within the viral factories at
early times of infection, while eIF4G and eIF4E are surrounding these areas at late times. In fact, other components of
translational machinery such as eIF2a, eIF3b, eIF4E, eEF2 and ribosomal P protein are enriched in areas surrounding ASFV
factories. Notably, the mitochondrial network is polarized in ASFV-infected cells co-localizing with ribosomes. Thus,
translation and ATP synthesis seem to be coupled and compartmentalized at the periphery of viral factories. At later times
after ASFV infection, polyadenylated mRNAs disappear from the cytoplasm of Vero cells, except within the viral factories.
The distribution of these pools of mRNAs is similar to the localization of viral late mRNAs. Therefore, degradation of cellular
polyadenylated mRNAs and recruitment of the translation machinery to viral factories may contribute to the inhibition of
host protein synthesis, facilitating ASFV protein production in infected cells.
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Introduction
The vast majority of animal cytolytic viruses interfere with
cellular gene expression after infection of host cells. Cellular
protein synthesis in particular is usually abrogated at times when
late viral proteins are being synthesized [1–3]. However, the
molecular mechanisms by which viruses induce this phenomenon
are still under investigation. Eukaryotic initiation factor (eIF) 4F is
composed of eIF4E, eIF4A and eIF4G (Figure 1A). eIF4E binds
the cap structure present at the 59 end of cellular mRNAs; eIF4A is
an RNA helicase that unwinds the secondary structure near to the
initiation codon and eIF4G is a scaffolding protein that physically
links the mRNA and the small ribosomal subunit by means of
several protein-protein interactions [4]. In particular, the N-
terminal domain of eIF4G binds to eIF4E and poly(A)-binding
protein (PABP), which are involved in mRNA recruitment through
interaction with the cap and the poly(A) tail, respectively (scheme
in Figure 1A) [5,6]. The C-terminal domain of eIF4G interacts
with eIF4A, mitogen-activated kinase 1 (Mnk-1) and eIF3, a
complex eIF that binds the 40S ribosomal subunit [4]. In addition,
eIF4F functions are regulated by extra- and intracellular signals in
eukaryotic cells by means of phosphorylation processes [7,8]. In
example, Pak-2 phosphorylate eIF4GI at the eIF4E-binding site,
inhibiting the interaction between both factors [7]. On the other
hand, eIF4E is phosphorylated by the protein kinase Mnk-1,
although the role of this event is still under investigation [2,9]. In
addition, there are several eIF4E-binding proteins (4E-BPs) that
have the ability to sequester eIF4E in a phosphorylation-
dependent manner [9,10]. In their hypophosphorylated form,
4E-BPs inhibit cap-dependent translation on interacting with
eIF4E. In contrast, hyperphosphorylation of 4E-BPs by mTOR
kinase leads to their release from eIF4E and subsequent
association with eIF4G, thereby assembling an active eIF4F
complex [9,10].
Given the essential role of eIF4F in cellular mRNA translation,
it is not surprising that many animal viruses target eIF4F during
the viral cycle [2,3]. This is the case of some picornaviruses,
retroviruses and caliciviruses, which encode proteases that cleave
eIF4G, separating its N-terminal and C-terminal domains [11].
Other viruses such as encephalomyocarditis virus (EMCV),
adenoviruses (AdV) or vesicular stomatitis virus (VSV) induce
the dephosphorylation of eIF4E and 4E-BPs, leading to inactiva-
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tion of cap-dependent translation [12–15]. By contrast, mRNAs
synthesized by some DNA viruses, such as herpes simplex virus
type 1 (HSV-1), human citomegalovirus (HCMV) or vaccinia virus
(VV), are translated by a cap-dependent mechanism. These viruses
can in fact stimulate eIF4F assembly to enhance viral protein
synthesis [16–19]. In addition to eIF4F, the phosphorylation of
eIF2a may play a key role in the regulation of cellular and/or viral
translation [3]. eIF2a is a subunit of eIF2, a multiprotein complex
responsible for binding the initiator Met-tRNAi to the 40S
ribosomal subunit. Phosphorylation of eIF2a impairs the exchange
of GDP for GTP mediated by eIF2B [20,21]. In mammalian cells,
four protein kinases are able to phosphorylate eIF2a, but the
double-stranded RNA-activated kinase PKR is of major impor-
tance in the regulation of translation during viral infection [22].
Subsequently, some animal viruses have developed different
strategies to counteract PKR activation [3].
African swine fever virus (ASFV), the sole member of the
Asfarviridae family [23], is a large and complex cytoplasmic DNA
virus of icosahedral symmetry that infects different species of
swine, causing acute and often fatal disease. Infection by ASFV is
characterized by the absence of a neutralizing immune response,
which has so far hampered the development of a conventional
vaccine. ASFV replicates exclusively within the host cell cytosol,
although a nuclear step has been also reported [24]. Indeed,
discrete cytoplasmic areas are reorganized into replication sites,
known as factories, during the productive virus cycle [25]. Analysis
of the complete DNA sequence of the 170-kb genome of the
BA71V isolate, adapted to grow in Vero cells, has revealed the
existence of 151 genes, including those coding for structural
proteins, a number of enzymes with functions related to DNA
replication, gene transcription and protein modifications, as well as
several genes able to modulate virus-host interaction. Moreover,
ASFV induces the activation of caspase-3 and p53 and is able to
interfere with inducible gene transcription, leading to immune
evasion [26–29]. Transcription of ASFV genes gives rise to cap
and polyadenylated mRNAs, however, the regulation of transla-
tional machinery in ASFV-infected cells has not been studied. In
spite of encoding a variety of enzymatic activities [30,31], ASFV is
fully dependent on the cellular translational machinery to
synthesize viral proteins. In the present work, a number of eIFs
are analyzed in ASFV-infected cells. We provide evidence that
eIF4E and eIF4G are phosphorylated at Ser209 and Ser1108
respectively and these events strongly correlate with a robust viral
protein synthesis and an increase of eIF4F assembly. Inhibition of
either eIF4GI or eIF4E phosphorylation partially affects viral
protein synthesis and virus spread, whereas the knock down of
these factors strongly avoid ASFV infection. On the other hand,
eIF4GI and eIF4E are recruited within ASFV factories at 8 hpi,
and they are later redistributed to the periphery of these particular
foci. Finally, eIF4GI, eIF4E, eIF2a, eIF3b, eEF2 and ribosomes
are closely distributed to ASFV factories at 16 hpi, being ASFV
late mRNAs and mitochondrial network found at these areas.
Materials and Methods
Cell culture, viruses, and reagents
Vero and COS-7 (African green monkey kidney) cells were
obtained from the American Type Culture Collection (ATCC) and
grown in Dulbecco’s Modified Eagle’s Medium supplemented with
5% fetal bovine serum (Invitrogen Life Technologies). Cells were
grown at 37uC under a 7% CO2 atmosphere saturated with water
vapor in a culture medium supplemented with 2 mM L-glutamine,
100 U/ml gentamicin and nonessential amino acids. The Vero-
adapted ASFV strain Ba71V was propagated and titrated by plaque
assay on Vero cells, as described [26–29]. Infection of Vero and
COS-7 cells with Ba71V ASFV was carried out at a multiplicity of
1–5 pfu/cell. Silencing was achieved by transfecting COS-7 or
Vero cells twice (0 and 24 h) with 25 nM siRNAs (siControl [Gene
Link], si4E [TACATTAATCGGTAGCAGGAA] [32], si4GII-2
[CAAAGACCTGGACTTTGAA] (EW, AC, PM and LC, unpub-
lished data) and si4GI-31 [CCCAUACUGGAAGUAGAAGTT]
[33]) using lipofectamine 2000 (Invitrogen) according to the
manufacturer’s recommendations. Chemical inhibitors were dis-
solved as 10006 stocks in DMSO and used at the concentrations
indicated. Rapamycin (Calbiochem) and CGP57380 (Sigma) were
used at 250 nM and 20 mM, respectively. Cells were pretreated
with rapamycin or CGP57380 12 h before infection with ASFV and
the experiments were carried out in the continuous presence of
either inhibitor. Apoptosis was induced using 0.5 or 1 mM
staurosporin (Sigma). Caspase activity was prevented by incubation
with 60 mM Q-VD-Oph (Calbiochem) or Z-VAD fmk (Bachem).
Cytosine arabinoside (AraC) (Sigma) was used at 40 mg/ml.
Protein synthesis and Western blot analysis
Synthesis of cellular and ASFV proteins was analyzed by
metabolic labelling with 200 mCi of [35S]Met-[35S]Cys/ml
(Promix; Amersham Biosciences) for 2 h, followed by SDS-PAGE,
fluorography and autoradiography. Mock-infected or ASFV-
infected cells were washed twice with PBS and lysed in lysis
buffer or RIPA modified buffer supplemented with protease and
phosphatase inhibitor cocktail tablets. The protein concentration
was determined by the bicinchoninic acid spectrophotometric
method (Pierce). Cell lysates (30 mg of protein) were fractionated
by SDS-PAGE and electrophoretically transferred to an Immo-
bilon extra membrane (Amersham). For autoradiography, the gel
was exposed on a Fujifilm BAS-MP 20405 imaging plate at room
temperature. The exposed imaging plate was analyzed with a Fuji
BAS 1500 analyzer. The steady-state level and the integrity of
initiation factors were analyzed by Western blot. eIF4GI was
detected with antisera raised against peptides derived from the N-
terminal and C-terminal region of human eIF4GI at 1:1000
dilution [34]. Rabbit antisera against N-terminal and C-terminal
Author Summary
African Swine Fever Virus (ASFV) is a large DNA virus that
infects different species of swine, causing an acute, highly
contagious and often fatal disease. Infection by ASFV is
characterized by the absence of a neutralizing immune
response, which has so far hampered the development of
a conventional vaccine. While a number of reports have
been concerned with ASFV genes and mechanisms
regulating programmed cell death and immune evasion,
nothing is known so far regarding how ASFV replicates in
the infected cells. As intracellular parasites, viruses are
highly dependent on host translation machinery for
synthesizing their own proteins. We have observed that
the cellular protein synthesis is strongly inhibited during
ASFV infection, while viral proteins are efficiently pro-
duced. Furthermore, we here describe the processes by
which ASFV activates and redistributes the cellular
machinery to synthesize its own proteins. It has been
reported that ASFV replicates within discrete cytoplasmic
areas known as factories. In this regard, we have identified
the presence of important cellular factors involved in the
control of protein synthesis, located close to viral factories,
together with ribosomes and the mitochondrial network,
which represents a sophisticated mechanism of viral
control.
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region of eIF4GII (a generous gift from N. Sonenberg, McGill
University, Montreal, Canada) were employed at 1:500 dilution.
eIF4A was detected with a mouse monoclonal antibody (a
generous gift from Dr. H. Trachsel, Institute for Biochemistry
and Molecular Biology, University of Berne, Switzerland) at 1:50
dilution. Anti-eIF2a, anti-p-eIF4E (Ser209), anti-eEF2, anti-Mnk-
1, anti-PKR (Santa Cruz Biotechnology), anti-p-eIF2a (Ser52)
(Invitrogen), anti-eIF4E (BD Transduction laboratories), anti-p-
eIF4GI (Ser1108), anti-Caspase-3, anti-p-Mnk-1 (Thr197/202)
(Cell Signalling), anti-a-Actin, anti-PTB and anti-a-Tubulin
(Sigma) were employed according to the manufacturer’s recom-
mendations. Anti-4E-BP1 (Santa Cruz Biotechnology), anti-
nonphospho-4E-BP1 (Thr46) and anti-phopho-4E-BP1 (Thr70)
(Cell Signalling) were used at 1:1000 dilution. To detect ASFV
proteins, polyclonal antibodies raised against p72 or p32
polypeptides or against complete ASFV virus, were used at
1:1000 dilution. Anti-rabbit, anti-mouse (Promega) and anti-goat
(Santa Cruz Biotechnology) immunoglobulin G antibodies cou-
pled to peroxidase were used at 1:5000 dilution. The percentage of
protein synthesis and steady-state levels of each protein was
estimated by densitometric scanning of the corresponding band.
Sepharose-4B-m7GTP matrix
Vero cells were infected with 3 pfu/cell of ASFV. At the
indicated times, cells were harvested and lysed in buffer A
(150 mM NaCl, 1.5 mM MgCl2, 10 mM Tris-HCl [pH 8.5],
0.2% Igepal) with proteases, phosphatases, and RNase inhibitors
as described above. The lysates were centrifuged at 10,0006 g,
and the supernatants were incubated with Sepharose-m7GTP
(Amersham) or Sepharose-4B (Sigma), as a negative control,
overnight at 4uC. The resins were washed five times with buffer A,
resuspended in Laemmli sample buffer, and analyzed by SDS-
polyacrylamide gel electrophoresis and Western blotting [35].
Immunofluorescence microscopy and FISH
Fixation, permeabilization and confocal microscopy were
performed as described previously [36], employing a confocal
Figure 1. Inhibition of host protein synthesis and analysis of caspase-3-mediated eIF4GI cleavage in ASFV-infected cells. A)
Schematic representation of translation initiation complex. B) Cellular and viral protein synthesis during ASFV infection. Cultures of Vero cells (56105)
were mock infected (Mock) or infected with ASFV (5 pfu/cell), and labeled at different times after infection with 200 mCi of [35S]Met-[35S]Cys/ml in
cysteine-methionine-free medium for 2 h. Samples were analyzed by SDS-PAGE followed by fluorography and autoradiography. C) Activation of
caspase-3 during ASFV infection induces incomplete eIF4GI degradation. eIF4GI was detected by Western blot by incubation with specific antiserum
at the indicated times after ASFV-infected Vero cells. D) eIF4GII (upper panel) and cleaved caspase-3 (bottom panel) were analyzed by Western
blotting. E) Analysis of eIF4G1 cleavage by using specific caspase-3 inducers or inhibitors in mock-infected or ASFV-infected cells. Vero cells were
treated with 0.5 or 1 mM staurosporin or were infected with ASFV (5 pfu/cell). Two replicates of mock-infected or ASFV-infected cells were treated
with 60 mM Q-VD-Oph or Z-VAD. Cells were recovered after 18 h in sample buffer and eIF4GI (upper panel) and caspase-3 (bottom panel) activation
was analyzed by Western blot. c.p., cleavage product; C-3, cleaved caspase-3 (17 KDa); STP, staurosporin.
doi:10.1371/journal.ppat.1000562.g001
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LSM510 coupled to an Axiovert 200 M microscope (Zeiss). A
rabbit antibody raised against the C-terminal domain of eIF4GI
was used at 1:1000 dilution. Monoclonal anti-eIF4E antibody was
employed at 1:100 dilution. eIF2a, eIF3b (p110) and eEF2 was
detected with the corresponding antibodies at 1:50 dilution. ASFV
p72 protein was localized by using specific rabbit or mouse
antibodies generated in our laboratory. Eukaryotic ribosomal P
protein was detected with a mouse monoclonal antibody (a
generous gift from J.P. Garcı´a-Ballesta, Centro de Biologı´a
Molecular ‘‘Severo Ochoa’’, Madrid) (1:10 dilution) [37]. For
mitochondria staining, cells were incubated with 2 mM Mito-
Tracker red CMH2-Ros (Molecular Probes) for 45 min before
fixation. Fluorescence in situ hybridization (FISH) with fluorescein
labeled oligo d(T) (Gene Link) was carried out as previously
reported [38]. FISH using specific fluorescein-tagged probes
against A224L [GCTTTGATTTCGTGCATCTATGGAGC]
and p72 [CGCAGGTGACCCACACCAACAATAACCAC]
mRNAs was carried out as follows: cells were fixed and
permeabilized and then washed tree times: first with PBS 1X,
the second washed with PBS 1X and SSC 1X and the third one
with SSC 2X. Next, cells were incubated at 37uC with the pre-
hybridation buffer (SSC 2X, 20% deionized formamide, 0.2%
BSA and 1 mg/ml yeast tRNA). After, cells were incubated at 42u
with the hybridation buffer (SSC 2X, 20% deionized formamide,
0.2% BSA, 1 mg/ml yeast tRNA, 10% dextran sulphate and
1 pmol/ml of either p72 or A224L probes) for 4 h. Preparations
were washed four times at 55u for 5 min: the first washed was
performed with SSC 2X mixed with 20% formamide; the second
one was carried out with SSC 2X; the third one with SSC 1X and
PBS 1X and the last one with PBS 1X. FISH was followed with
the immunofluorescence protocol. Image processing was per-
formed with Huygens 3.0 software.
Cell processing for electron microscopy
At the times indicated, Vero cells were fixed with 2%
glutaraldehyde in 0.2 M HEPES buffer (pH 7.4) for 1 h at room
temperature and immediately scraped off the plate. For immu-
noelectron microscopy, cells were processed by freeze substitution.
Immunogold localization of eukaryotic ribosomal P protein was
done by placing the ultrathin sections on drops of different
solutions. After incubating for 30 min with TBG (TBS [Tris-HCl
30 mM, NaCl 150 mM, pH 8.2] supplemented with 0.1% BSA
and 1% gelatin from cold water fish skin), sections were floated for
1 h on a drop of anti-P antibodies diluted in TBG. The grids were
then washed in TBS supplemented with 0.1% BSA (365 min) and
then exposed to 10 nm colloidal gold conjugated goat anti-rabbit
IgG diluted in TBS for 1 h. Then, the grids were washed
consecutively with TBG, TBS, and distilled water (5 min each)
before being stained with a solution saturated of uranyl acetate
followed by lead citrate.
Accession numbers
ASFV proteins in Swiss Prot database. p72: MCP_ASFB7;
A224L: IAP_ASFB7; p32: P30_ASFB7; p10: P10_ASFB7; p17:
P17_ASFB7; g5R: DIPP_ASFB7, p12: P12_ ASFB7; DP71L:
Q65212. eIFs from Macaca mulata in ENSAMB database.
eIF4GI: ENSMMUG0000010934; eIF4E: ENSMMUG00000011066;
eIF4A: ENSMMUG00000009590.
Results
eIF4GI level remains unaltered upon ASFV infection
Very little is known about the regulation of translation in ASFV-
infected cells, including the mechanisms by which ASFV shuts off
host protein synthesis. ASFV infection triggers caspase-3 activation
during infection [39,40]. Since apoptosis impairs protein synthesis,
leading to cleavage of eIF4GI, integrity of this initiation factor was
first analyzed in ASFV-infected Vero cells. Cellular mRNA
translation was inhibited at 8 hours post infection (hpi) (,65%)
(Figure 1B, lane 2) and abolished at 18 hpi, such that only viral
proteins were synthesized after this time (Figure 1B, lane 3).
Finally, translation of ASFV mRNAs was also inhibited at later hpi
(Figure 1B, lanes 4 and 5). Interestingly, eIF4GI remained intact at
8 hpi, although cellular protein synthesis was significantly
inhibited at this time (Figure 1B and C). eIF4GI cleavage products
were detected from 16 hpi (Figure 1C), likely due to the effect of
caspase-3 activity. In agreement with this hypothesis, procaspase-3
started to be processed to caspase-3 from 8 hpi, such that high
amounts of active caspase-3 were detected after 18 and 24 hpi
(Figure 1D, upper panel) [39]. However, levels of intact eIF4GI
and eIF4GII were not significantly altered under these conditions
(Figure 1C and D, bottom panel). To assess whether caspase-3 is
responsible of eIF4GI proteolysis upon ASFV infection, eIF4GI
cleavage products induced by the apoptosis inductor staurosporine
(STP) in uninfected Vero cells were examined. Similar eIF4GI-
derived polypeptides were observed both in ASFV-infected cells
and in STP-treated Vero cells (Figure 1E, lanes 4 and 5 vs 7). In
both cases, caspase-3 was detected by Western blot, suggesting the
induction of apoptosis (Figure 1E, bottom panel). Moreover,
eIF4GI cleavage products in ASFV-infected cells were prevented
by addition of caspase inhibitors Q-VD-Oph or Z-VAD, to the
culture medium (Figure 1E, lane 8 and 9). Therefore, steady-state
levels of intact eIF4GI and eIF4GII were not significantly
diminished throughout the infection course, suggesting that the
pool of intact eIF4G is enough to support cap-dependent
translation in ASFV infected cells.
ASFV hinders eIF2a phosphorylation and induces the
activation of cap-dependent translation factors
A number of cellular protein kinases phosphorylate eIF2a
[20,21]. RNA-dependent protein kinase (PKR) and PKR-like
endoplasmic reticulum kinase (PERK) are activated during many
viral infections by the generation of viral dsRNA or by the
accumulation of viral proteins in the endoplasmic reticulum (ER),
respectively [41,42]. Recently, it has been proposed that GCN2
phosphorylates eIF2a upon binding to specific viral RNA
sequences [43]. In most cases, phosphorylation of eIF2a blocks
viral protein synthesis, hampering virus spread [3]. Phosphoryla-
tion of eIF2a was examined in extracts from ASFV-infected cells
by Western blot analysis using a specific phospho-eIF2a antibody.
As a positive control of eIF2a phosphorylation, Vero cells were
infected with Sindbis virus (SV) [44]. Infection with SV led to a
potent phosphorylation of eIF2a compared to mock-infected cells
(Figure 2A, upper panel), whereas phosphorylated eIF2a was
undetectable in ASFV-infected cells throughout infection
(Figure 2A, bottom panel). In addition, eIF2a levels were similar
in each lane (Figure 2A, bottom panel), reflecting that eIF2a
remains unphosphorylated in ASFV-infected cells despite the fact
that PKR levels remained unaltered (Figure 2A, bottom panel).
Thus, these data indicate that ASFV prevents eIF2a phosphor-
ylation in infected cells, although the molecular mechanism
involved is still unknown.
Many RNA and DNA viruses alter the activity of eIF4F by
modifying the phosphorylation status of some of its components
[2,16]. To determine whether eIF4E is modified on ASFV
infection, samples were taken at 4, 6, 8, 14 and 18 hpi and
phosphorylation of eIF4E was analyzed by Western blot. Notably,
eIF4E phosphorylation increased after ASFV infection of Vero
Control of Protein Synthesis by ASFV
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Figure 2. Effect of ASFV infection on total level and phosphorylation status of eIF2a, eIF4E, eIF4GI and 4E-BP1. A) Steady-state levels
of eIF2a, phospho-eIF2a and PKR. At the indicated times after ASFV infection, Vero cells (MOI = 5 pfu/cell) were solubilised in sample buffer and
equivalent amounts of protein were analyzed by Western blot with specific antisera. B) Phosphorylation of Mnk-1 and eIF4E is stimulated in ASFV-
infected Vero cells. Vero cells were either mock-infected (Mock) or infected with ASFV (MOI = 5 pfu/cell). At the indicated times (hpi), total protein was
isolated, and equivalent amounts were fractionated by SDS-PAGE, and analyzed by immunoblotting using antisera recognizing phospho-eIF4E (P-
eIF4E), total eIF4E, phospho Mnk-1 (P-Mnk-1), eIF4A and eEF2. C) The phosphorylation status of 4E-BP1 was analyzed using antibodies against total
4E-BP1 (upper panel), phopho-4E-BP1 (Thr70) (middle panel) and non-phospho-4E-BP1 (Thr46) (bottom panel). D) ASFV infection increases level of
phosphorylated eIF4G through mTOR activation. Vero cells were non-treated or pretreated for 12 h with rapamycin 250 nM and then infected with
5 pfu/cell of ASFV. Cells were then lysed with buffer sample at 4, 8 and 18 hpi. Amounts of phospho-eIF4GI and total eIF4GI were analyzed by
Western blot (upper panels). The phosphorylation status of Mnk-1 in the absence or presence of rapamycin was analyzed by using specific antiserum
anti-phospho-Mnk-1 (middle-bottom panel). a-Tubulin was detected as a load control (bottom panel). E) The ASFV-induced phosphorylation of eIF4G
and Mnk-1 requires late events of the viral cycle. ASFV-infected Vero cells were treated with AraC (40 mg/ml) throughout the infection course. Cells
were then lysed and 30 mg of protein were subjected to electrophoresis and analyzed by Western blot with specific antisera against eIF4GI, phospho-
eIF4GI (upper panels) and phospho-Mnk-1 (middle-bottom panel). a-Tubulin was detected with a specific antibody as a load control (bottom panel).
doi:10.1371/journal.ppat.1000562.g002
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cells (Figure 2B). Indeed, maximal eIF4E phosphorylation was
achieved at 14–18 hpi, correlating with robust synthesis of viral
protein (Figure 2B, lanes 5 and 6 vs Figure 1B, lane 3), while levels
of total eIF4E or eIF4A were similar in each case (Figure 2B).
Mnk-1 is responsible for eIF4E phosphorylation at Ser209. This
kinase is activated by phosphorylation by p38 or Erk [17].
Interestingly, ASFV infection led to a potent phosphorylation of
Mnk-1 at 14 and 18 hpi, which correlated with a significant
increase of eIF4E phosphorylation (Figure 2B). It is well
established that 4E-BPs act as inhibitors of cap-dependent
translation, since they compete with eIF4G for eIF4E binding.
The inhibitory activity of 4E-BPs is modulated by phosphoryla-
tion, mediated by mTOR kinase [9,45]. To detect the phosphor-
ylation status of 4E-BP1 in ASFV infected cells, antibodies raised
against total 4E-BP1, phosphorylated 4E-BP1 at Thr70 or non-
phosphorylated 4E-BP1 at Thr46 were used in Western blotting
assays. The antibody against total 4E-BP1 pool identified three
polypeptides with different electrophoretic mobility, corresponding
to different levels of 4E-BP1 phosphorylation [16]. In contrast to
that observed in VV- and HSV-1-infected cells, 4E-BP1 was
hyperphosphorylated at early times post infection, but it was
progressively dephosphorylated from 14 hpi (Figure 2C, upper
panel). These results were further reinforced by the observations
obtained with the specific antibodies that recognize phosphory-
lated and non-phosphorylated forms of 4E-BP1. Thus, phosphor-
ylation at Thr70 of 4E-BP1 was shown to be significant at early
times post infection, decreasing gradually from 14 hpi (Figure 2C,
middle panel). Consistent with these findings, the level of non-
phosphorylated 4E-BP1 dropped at 4 hpi, but increased at 14 and
18 hpi (Figure 2C, bottom panel). On the other hand, we were
unable to detect a decrease on 4E-BP1 levels throughout the
infection course (Figure 2C), in contrast to the results described for
VV-infected cells [16]. Therefore, we can conclude that 4E-BP1 is
phosphorylated at early times upon ASFV infection, whereas it is
progressively dephosphorylated from 14 hpi.
eIF4GI is phosphorylated at Ser1108 in response to serum
stimuli and upon the infection of many DNA viruses [8,46–48]. To
examine whether eIF4GI is phosphorylated after ASFV infection,
a Western blot using specific phospho-eIF4GI antibody was
carried out. Notably, eIF4GI was potently phosphorylated at
Ser1108 in ASFV-infected cells at 4, 8 and 18 hpi, while total
eIF4GI remained unaffected (Figure 2D). The phosphorylation of
eIF4GI coincides with the highest ratio of ASFV protein synthesis
observed from 8 to 18 hpi (Figure 1B, lanes 2 and 3). In order to
test the participation of mTOR in the phosphorylation of eIF4GI,
Vero cells were pre-incubated for 12 h with 250 nM rapamycin
and then infected with ASFV (MOI 5 pfu/cell) in presence of the
compound. Under these conditions, eIF4GI was kept unpho-
sphorylated in both mock and ASFV-infected cells throughout the
infection course (Figure 2D). These data support the idea that
ASFV requires mTOR activity to induce the phosphorylation of
eIF4GI. It is noteworthy that Mnk-1, which is not a substrate for
mTOR [17], was phosphorylated in ASFV-infected cells despite
rapamycin incubation (Figure 2D). Cytosine arabinoside (AraC)
blocks the late phase of gene expression in ASFV-infected cells
[39]. To elucidate whether ASFV late proteins are required to
provoke eIF4GI and Mnk-1 phosphorylation, Vero cells were
infected with ASFV and immediately treated with AraC. In the
presence of AraC, eIF4GI as well as Mnk-1 were not
phosphorylated (Figure 2E). These findings reveal that both
eIF4GI and Mnk-1 phosphorylation requires the expression of
ASFV late genes.
eIF4E is sequestered by 4E-BPs when cap-dependent translation
is inhibited. However, several stimuli elicit the disruption of this
complex leading to the interaction of eIF4G and eIF4E, in turn
activating cap-dependent translation [9]. Since eIF4E and eIF4GI
phosphorylation is altered in ASFV-infected cells, the ability of
eIF4GI to bind eIF4E was assayed. To this end, extracts derived
from mock or ASFV-infected cells (MOI = 5 pfu/cell) were
incubated with a sepharose-4B-m7GTP matrix or sepharose-4B
as a control. After pull down, the amount of eIF4E and eIF4GI were
examined by Western blot. Similar quantities of eIF4E, eIF4GI and
a-Tubulin were detected in total fractions from mock and ASFV-
infected cells. Furthermore, the amount of eIF4E associated with
sepharose-4B m7GTP matrix was similar in extracts from mock or
ASFV-infected cells (Figure 3A). As expected, eIF4E was not
detected in control sepharose-4B fractions (data not shown).
Interestingly, eIF4GI increased in sepharose-4B-m7GTP matrix
fractions from 4 to 16 hpi, compared with mock cells (Figure 3A).
This result indicates that enhancement of eIF4F assembly takes
place at early times post infection. In contrast, a-tubulin was only
found in the total extracts of both infected and uninfected cells
(Figure 3A). 4E-BP1 disappeared from the m7GTP matrix fractions
from 4 to 8 hpi, consistent with the increase of eIF4F formation
(Figure 3A). It is noteworthy that although 4E-BP1 was enriched in
these fractions at 16 hpi, (in agreement with the data showed above
in Figure 2C), a concomitantly decrease on eIF4F assembly at this
time could not be observed (Figure 3A). Further experiments
beyond this work will be carry out to fully determine whether the
4E-BP1 hypophosphorylation, found at later times post infection,
might be involved in the reduction of eIF4F formation and therefore
possibly involved in the control of the final steps of viral protein
synthesis.
Next, the role of eIF4GI, 4E-BPs and eIF4E phosphorylation in
eIF4F assembly in ASFV-infected cells, was examined using
specific inhibitors of either mTOR kinase (rapamycin) or Mnk1
(CGP57380). Rapamycin treatment significantly increases the
association of 4E-BP1 with eIF4E and, consequently, the presence
eIF4GI in m7GTP matrix fractions was not enhanced upon ASFV
infection (Figure 3B upper pannel), conversely to that observed in
untreated cells (Figure 3A, upper panel). Thus, we conclude that
the inhibition of mTOR prevents the stimulation of eIF4F
assembly detected in ASFV-infected cells. In contrast to these
results, treatment with CGP57380 did not avoid the stimulation of
eIF4E-eIF4GI interaction, triggered after ASFV infection
(Figure 3C). In the presence of the Mnk-1 inhibitor, a lower level
of 4E-BP1 was found at 4 hpi in m7GTP matrix, followed by an
increase after 8 hpi (Figure 3C, bottom panel). Consequently,
eIF4E-eIF4GI interaction slightly diminished at 16 hpi, therefore
suggesting that the prevention of eIF4E phosphorylation observed
in ASFV-infected cells, likely favour the binding of 4E-BP1 to
eIF4E in a scenario in which 4E-BP1 dephosphorylation is
enhancing (Figure 3C and 2C), although other hypothesis could be
not discarded.
Interestingly, rapamycin, as well as CGP57380 treatment,
induced a moderate inhibition of ASFV protein synthesis, since a
diminution on p72, p32, p17 and p10 accumulation was achieved
in treated cells, especially at early times post infection (Figure 3D
and E). In addition, both compounds diminished moderately but
reliably virus spread (Figure 3F).
Therefore, the increase of eIF4F assembly observed in ASFV-
infected cells might enhance the synthesis of viral proteins but
seems to be not essential for the progression of the infection.
However, previous studies with HSV-1 revealed that the impact of
Mnk-1 inhibition by CGP57380 in viral protein synthesis is
inversely proportional to the multiplicity of infection used [17].
Therefore, further experiments are likely required to fully address
the role of eIF4E phosphorylation in ASFV-infected cells.
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Depletion of eIF4E and eIF4GI abrogates ASFV infection
The above experiments illustrate that ASFV infection enhances
eIF4F activity to maximize the synthesis of its own proteins. To
examine the extent to which cap-dependent translation is essential
for ASFV, eIF4E or eIF4GI were depleted in COS-7 cells using
the previously described siRNAs [32,33]. At 48 hours post
transfection, eIF4E- and eIF4GI-silenced cells were infected with
ASFV (MOI = 1 pfu/cell). At 16 hpi, immunofluorescence was
performed using antibodies against eIF4E and eIF4GI. A specific
antibody that recognizes ASFV-p72, the major capsid protein,
which has been previously shown to localize in viral factories, was
also employed to test both the infection progress and as a viral
factory marker. To-Pro-3 was used in parallel to detect cellular
nuclei and viral factories. As shown in Figure 4A and B, the
amount of eIF4E or eIF4GI was significantly lower in cells
transfected with si4E or si4GI-31 siRNAs, respectively, compared
with control cells (Figure 4A and B). Interestingly, p72 was almost
undetectable in most eIF4E-silenced cells (Figure 4A). In fact, the
percentage of cells that synthesize p72 dropped to 5% in cells with
eIF4E depletion, as compared to 60% of control infected cells that
were positive for p72 (Figure 4C). Notably, in some of the eIF4E-
silenced cells, several small structures appeared upon ASFV-
infection, possibly corresponding to aberrant viral factories, which
did not react with p72 antibodies (Figure 4A). In parallel, when
Figure 3. Analysis of cap-binding complex during ASFV-infection. A) Interaction of eIF4GI with eIF4E is increased upon ASFV infection. Vero
cells were infected with 5 pfu/cell of ASFV and lysed at 4, 8 or 16 hpi with buffer A. Cell extracts were then incubated with Sepharose 4B matrix
followed by Sepharose-4B-m7GTP matrix. Cap-binding complexes were eluted with Laemmli sample buffer. eIF4E, eIF4GI, a-Tubulin and 4E-BP1 were
detected in total and eluted fractions by Western blotting. B and C) eIF4GI-eIF4E association is abrogated by rapamycin but not by CGP57380. Vero
cells were pretreated with 250 nM rapamycin (B) or 20 mM CGP57380 (C). After 12 h cells were infected with ASFV (5 pfu/cell) in the continuous
presence of the compounds. At 4, 8 and 16 hpi cells were recovered in buffer A and then incubated with Sepharose 4B matrix followed by Sepharose-
4B-m7GTP matrix. eIF4GI, eIF4E, a-Tubulin and 4E-BP1 were detected in total and eluted fractions by Western blotting. D, E and F) Rapamycin and
CGP57380 treatments only partially inhibit ASFV protein synthesis and virus spread. Vero cells were either pretreated or not with 250 nM rapamycin
(D) or 20 mM CGP57380 (E). After 12 h cells were infected with ASFV (5 pfu/cell) in the continuous presence of the compounds. At 6, 16 and 24 hpi
cells were recovered and viral proteins were analyzed with p72 (D and E, upper panel) and p32 (E, upper-middle panel) antibodies or an antisera that
recognize most of the ASFV structural proteins (D and E middle-bottom panel). Phosphorylation of 4E-BP1 or eIF4E was analyzed with
phosphospecific antibodies against Thr70 (D, bottom panel) and Ser209 (E, bottom panel), respectively. F) After 48 h of ASFV infection, supernatants
from rapamycin or CGP57380 treated or untreated cells were recovered. Lytic viruses were titrated in Vero monolayers and plotted in the table. S.D.,
standard deviations.
doi:10.1371/journal.ppat.1000562.g003
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ASFV-infected cells lacking eIF4GI were analyzed, the percentage
of p72 positive cells not only decreased by about 20% (Figure 4B
and C), but the size of the viral factories also clearly diminished as
compared to non-silenced ASFV-infected COS-7 cells (Figure 4B).
To further reinforce these findings, COS-7 cells were transfected
with si4E, si4GI-31 or a mixture of si4E, si4GI-31 and si4GII-2.
After a recovering period (72 h), they were infected with ASFV
(1 pfu/cell). Cells were recovered in sample buffer at 18 hpi and
eIFs and viral proteins were examined by Western blotting. A
partial depletion (,60–70%) of eIF4E, eIF4GI or/and eIF4GII
was achieved using the different siRNAs (Figure 4D). These
siRNAs did not induce the unspecific silencing of other initiation
Figure 4. Depletion of eIF4E or/and eIF4GI blocks ASFV proteins expression in infected cells. A, B and C) COS-7 cells were transfected
with siControl, si4E or si4GI-31 in 2 steps separated by 24 hours. Cells were then seeded on glass coverslips and mock infected or infected with 1 pfu/
cell of ASFV. At 16 hpi, cells were permeabilised and fixed and ASFV p72 and eIF4E or eIF4GI were detected by indirect immunofluorescence. A and B)
Immunofluorescence using anti-eIF4E or anti-eIF4GI, respectively, and anti-p72 in either eIF4E (A) or eIF4GI (B) silenced cells. C) Percentage of cells
expressing ASFV p72 in eIF4E- and eIF4GI-silenced cells (mean6SD). * P,0.05. D) COS-7 cells were transfected with siControl, si4GI-31, si4E or a
mixture of si4GI-31, si4E and si4GII-2 (siMix) as indicated. After 72 h, cells were infected with 1 pfu/cell of ASFV and samples were recovered after
18 hpi. Depletion of eIFs was examined by Western blot against eIF4GI, eIF4GII and eIF4E (upper panels). Accumulation of viral proteins was analyzed
using a specific antibody against p72 (middle bottom panel) or with an antiserum that recognizes a number of structural ASFV proteins (bottom
panel). E, F and G) Vero cells were transfected with siControl, si4GI-31, si4E or a mixture of si4GI-31 and si4E (siMix) as described. After 72 h, cells were
infected with 1 pfu/cell of ASFV and samples were recovered after 18 hpi. Depletion of eIFs was examined by Western blot against eIF4GI and eIF4E
(E). Accumulation of viral proteins was analyzed using a specific antibody against p72 (F, upper panel) or with an antiserum that recognizes a number
of structural ASFV proteins (F, bottom panel). G) In parallel, supernatants from transfected cells were recovered at 48 hpi and titrated in Vero cells.
Virus titre in each case was indicated in the table. * unspecific cellular protein detected by the antibody.
doi:10.1371/journal.ppat.1000562.g004
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factors such as eIF3b, eIF2a, eIF4A and p97, as well as unrelated
cellular proteins such as a-Tubulin, polyC tract-binding protein
(PTB) or Ref-1 (EW, AC, PM and LC; unpublished data).
However, a partial decrease of eIF4E was detected in both si4GI-
31 transfected COS-7 and Vero cells. This effect was previously
described [33]. Interestingly, expression of ASFV proteins was
moderately reduced by silencing eIF4E or eIF4GI (Figure 4D).
Notably, simultaneous knock down of eIF4E, eIF4GI and eIF4GII
inhibited to a higher extent the synthesis of ASFV proteins
(Figure 4D, lane 5). Depletion of eIF4E and eIF4GI was more
effective in Vero cells, reaching a 90% of protein silencing in each
case (Figure 4E). Under these conditions, ASFV proteins were very
poorly detected by Western blot as compared to control cells
(Figure 4F), especially when eIF4E and eIF4GI were simulta-
neously depleted (Figure 4E and F, lane 6). In order to establish
the effect of eIF-depletion on ASFV production, the supernatants
obtained at 48 hpi from transfected Vero cells were titrated on
Vero monolayers, to analyze virus replication and spread. The
amount of lytic virus produced was severely reduced (,10 fold) by
the depletion of eIF4E and/or eIF4GI, as compared to control
cells (Figure 4G). Taken together, all these data indicate that both
eIF4E and eIF4G are important host factors for ASFV protein
synthesis and spread.
Translation initiation factors are recruited within the viral
factories in ASFV-infected cells
Two different groups have reported that eIF4GI and eIF4E are
located at viral factories in VV-infected cells [16,49]. The
subcellular localization of eIF4GI and eIF4E was examined in
ASFV-infected cells by immunofluorescence assays. eIF4GI and
eIF4E are spread in the cytoplasm of uninfected Vero cells
(Figure 5A and B), however, at 16 hpi, these initiation factors were
clustered at structures akin to viral factories and partially co-
localized with ASFV-p72 (Figure 5A and B). In contrast,
distribution of other cellular proteins such as a-Tubulin
Figure 5. eIF4E and eIF4GI are recruited to ASFV factories in infected cells. Vero cells were seeded on glass coverslips and mock infected or
infected with 5 pfu/cell of ASFV. At 16 hpi cells were permeabilized, fixed and then eIF4E (A) or eIF4GI (B) and ASFV p72 were detected by indirect
immunofluorescence. Cells were visualized by confocal microscopy and the cell outline was defined by phase contrast microscopy. C) In parallel, a-
Tubulin and p72 were detected in infected (right panels) and mock cells (left panels) with specific antibodies. Images were obtained under restricted
conditions and processed with Huygens 3.0 software.
doi:10.1371/journal.ppat.1000562.g005
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(Figure 5C), PTB or p53 (data not shown) [39], was not
significantly altered by ASFV infection. Interestingly, treatment
with AraC completely prevented the redistribution of eIF4GI and
eIF4E within ASFV factories, suggesting that the late viral gene
expression and/or the viral factory formation are required to elicit
the redistribution of eIFs (Figure S1). In addition, treatment with
cycloheximide (CHX) inhibited eIF4E and eIF4GI mobilization
when added at 4 hpi but not at 7 hpi, when late viral proteins
were being synthesized and early viral factories can be detected
(Figure S2). These data further reinforce the idea that viral
factories establishment and synthesis of late viral proteins might be
required for the reorganization of initiation factors in ASFV-
infected cells.
To determine in more detail the moment when eIF4GI and
eIF4E are mobilized to ASFV factories, localization of both
initiation factors was carried out at 4, 8, 16 and 24 hpi. Taking
into account that ASFV is a DNA virus, ToPro-3 was used to
visualize ASFV replicating sites [49]. As observed above, eIF4E
and eIF4GI were distributed throughout the cytoplasm of
uninfected Vero cells (Figure 6A). At 8 hpi, bright ToPro-3
stained foci were detected in the cytoplasm of infected cells.
Interestingly, both eIF4GI and eIF4E were found to be clustered
in these foci, while the amount of these initiation factors was
reduced in the rest of the cytoplasm (Figure 6A). Finally, at 16 and
24 hpi eIF4GI and eIF4E were mobilized to the periphery of viral
factories, correlating with a more clear accumulation of DNA in
the central area of this structure (Figure 6A). By this time after
infection, a similar localization was found for other translation
initiation or elongation factors such as eIF3b, eIF2a and eEF2
(Figure S3).
A further study revealed that eIF4GI is accumulated together
with viral DNA at 8 hpi (Figure 6B). At 10 hpi, p72 can be
detected and partially co-localized with cytoplasmic DNA, but
seems to be excluded from eIF4GI sites (Figure 6B). Thus, it can
be speculated that early ASFV factories might be compartmen-
talized in protein synthesis and morphogenesis areas. Finally,
components of ASFV factories were redistributed at later times
(18 hpi), showing three overlapping concentric areas: To-Pro-3
staining was more intense in the centre of the factory, while p72
accumulated at the periphery of this area and eIF4GI distributed
surrounding p72 (Figure 6B).
Localization of mRNAs in ASFV-infected cells
Some DNA viruses such as HSV and VV alter cellular mRNA
stability [50,51]. To test whether ASFV affects mRNA metabo-
lism, bulk polyadenylated mRNAs were detected in ASFV-
infected cells by FISH with oligo d(T)-fluorescein. Viral replication
foci were simultaneously stained with To-Pro 3. As a negative
control probe oligo d(A)-fluorescein was used. In uninfected Vero
cells, poly(A)-containing mRNAs localized to brightly staining foci
at the nucleus, which were excluded from nucleoli (Figure 7A and
B). By contrast, a diffuse distribution of cellular mRNAs was
observed in the cytoplasm of Vero cells (Figure 7A and B). As
expected, no fluorescence was detected in cells treated with oligo
Figure 6. eIF4E and eIF4GI redistribution during ASFV time-infection steps. A) Vero cells were seeded on glass coverslips and mock
infected or infected with 5 pfu/cell of ASFV. Cells were then permeabilized and fixed at 4, 8, 16 and 24 hpi. eIF4E and eIF4GI were detected by indirect
immunofluorescence and cell nuclei and ASFV factories were stained with To-Pro-3. Cells were visualized by confocal microscopy and the cell outline
was defined by phase contrast microscopy. Images were obtained under restricted conditions and processed with Huygens 3.0 software. B) Vero cells
were seeded on glass coverslips and mock infected or infected with 5 pfu/cell of ASFV. Cells were then permeabilized and fixed at 8, 10 and 18 hpi.
eIF4GI and p72 were detected by indirect immunofluorescence and cell nuclei and ASFV factories were stained with To-Pro-3. Cells were visualized by
confocal microscopy and the cell outline was defined by nomarski microscopy.
doi:10.1371/journal.ppat.1000562.g006
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d(A) probe, indicating that oligo d(T) induces a specific fluorescent
pattern (data not shown). Nuclear fluorescence increased in a time-
dependent manner in ASFV-infected cells, revealing that cellular
mRNA nuclear export is most likely impaired in ASFV-infected
cells (Figure 7A and B). Moreover, cytoplasmic staining with oligo
d(T) decreased throughout the infection course, and no mRNAs
could be found in infected cells at 16 hpi (Figure 7A and B), with
the exception of a polyadenylated mRNA bulk that was clustered
around ASFV factories from 8 to 16 hpi. It is likely that
polyadenylated mRNAs present around viral factories correspond
to ASFV mRNAs, as occurs in VV infected cells [49]. These
findings are also consistent with the idea that ASFV follows a
Figure 7. Localization of mRNAs in ASFV-infected Vero cells. Vero cells were seeded on glass coverslips and mock infected or infected with
5 pfu/cell of ASFV. At 8 and 16 hpi cells were fixed and permeabilized. Then, in situ hybridization with fluorescein labeled probes was carried out for
each post-infection time. A) Distribution of polyadenylated mRNAs bulk by using oligo d(T) fluoresecein labelled probe. To-Pro 3 was used to stain
cell nuclei and ASFV factories. B) Detail of mock infected and ASFV-infected cells, showing the polyadenylated mRNAs surrounding the viral factories.
In situ hybridization with fluorescein labeled p72 (C) and A224L (D) probes. To-Pro 3 and p72 antibody were used to detect cell nuclei and ASFV
factories. Cells were visualized by confocal microscopy and the cell outline was defined by phase contrast microscopy. Images were processed with
Huygens 3.0 software.
doi:10.1371/journal.ppat.1000562.g007
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strategy similar to other animal viruses to degrade cellular
mRNAs.
To determine the localization of viral mRNAs in ASFV-infected
cells, two fluorescein-tagged probes against p72 and A224L
mRNAs were used to carry out a FISH assay. Both probes gave
rise to a weak staining in the nuclei of mock infected cells, whereas
no fluorescence was observed in the cytoplasm (Figure 7C and D).
In agreement with oligo d(T) data, p72 and A224L probes
localized in cytoplasmic granules clustered in close proximity to
DNA- and p72-containing foci (Figure 7C and D). Thus, from
these experiments we can conclude that late viral mRNAs are
distributed at the periphery of ASFV factories, and probably are
coincident with the polyadenylated mRNAs detected at these sites
with oligo d(T) (Figure 7A and B vs C and D).
Ribosomes and mitochondria are clustered at the
periphery of ASFV factories
The above findings indicate that translation initiation factors are
located within ASFV factories. We then hypothesized that
ribosomes would be also recruited to ASFV replicative foci. To
test this possibility, a specific antibody against ribosomal acidic P
protein was employed, while ASFV-p72 antibody was used to
detect viral factories. Ribosomal P protein was spread throughout
the cytoplasm in uninfected Vero cells in a similar pattern to that
of initiation factors (Figure 8A). More interestingly, ribosomal P
protein partially co-localized with p72 protein in infected cells and
was clustered at the periphery of ASFV factories (Figure 8A),
suggesting that ribosomes are mobilized to the ASFV replicative
sites. To further analyze ribosome localization, immuno-gold
electron microscopy using anti-ribosomal P antibodies revealed
the presence of ribosomes in ASFV factories, in the proximity of
cytoplasmic regions where virus particles assemble (Figure 8B).
Therefore, protein synthesis seems to be restricted to ASFV
replicative foci since eIF4GI, eIF4E, eIF3b, eIF2a, eEF2 and P
ribosomal protein are all within viral factories. To our knowledge,
this is the first time that different components of the protein
synthesizing machinery, including eIFs, eEFs, mRNAs and
ribosomes, have been shown to be closely associated with viral
replicative foci.
Since viral macromolecular synthesis requires large amounts of
energy in the form of ATP, we next investigated the location of
mitochondria in ASFV-infected cells. In fact, previous findings
from our laboratory suggested that the mitochondrial network is
redistributed upon ASFV infection [52]. To examine mitochon-
drial distribution, the mitochondrial network was detected with
Figure 8. P ribosomal protein is clustered surrounding ASFV factories. A) Vero cells were seeded on glass coverslips and mock infected or
infected with 5 pfu/cell of ASFV. At 16 hpi cells were permeabilized, fixed and ribosomal P protein and ASFV p72 were detected by indirect
immunofluorescence by using specific antisera. Cells were visualized by confocal microscopy and the cell outline was defined by phase contrast
microscopy. Images were then processed with Huygens 3.0 software. B) Electron microscopy detection of ribosomes in ASFV-assembly areas. Cells
were infected with 5 pfu/cell of ASFV and processed for electron microscopy at 16 hpi. Ribosomes were detected using a specific monoclonal
antibody against P ribosomal protein.
doi:10.1371/journal.ppat.1000562.g008
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MitoTracker, while ribosomes were localized using anti-P protein
antibodies in ASFV-infected Vero cells at 16 hpi. The mitochon-
dria appeared uniformly distributed in the cytoplasm of control
Vero cells (Figure 9A), while accumulation of mitochondria was
evident at 16 hpi at the periphery of ASFV factories, co-localizing
partially with ribosomes (Figure 9A). These results indicate that
the mitochondrial network and ribosomes are recruited closely to
viral factories at late times of ASFV infection. These findings were
reinforced by electron microscopy experiments, since we found
that ribosomal P protein was enriched in the mitochondria-
containing area surrounding viral factories (Figure 9B). Thus, our
data provide evidence that ATP production, translation and viral
replication are in close proximity to maximize the effectiveness of
viral protein synthesis and DNA replication.
Discussion
Animal viruses rely upon the host translational machinery to
synthesize their own proteins since this process requires a large
number of macromolecules that cannot be all encoded by viral
genomes [3]. eIF4F is essential for the initiation of translation of
capped cellular mRNAs, but many viruses induce, directly or
indirectly, the inactivation of this complex [11]. During apoptosis
eIF4G is cleaved by the cellular protease caspase-3, correlating
with the inhibition of cellular protein synthesis [53]. Although
ASFV has been shown to activate caspase-3 [39,40], eIF4G
cleavage does not correlate with the inhibition of cellular mRNA
translation observed in infected cells. Furthermore, the level of
uncleaved eIF4G present during ASFV infection did not decrease
substantially, although caspase-3 derived cleavage products were
detected. It can be speculated that eIF4GI could be protected from
caspase-3 activity due to its location into the membranous
structures, derived from endoplasmic reticulum, which constitute
the ASFV factories, thus avoiding the accessibility of caspase-3 to
eIF4G. Alternatively, ASFV A224L gene produces an IAP-like
protein that inhibits caspase-3 activity [54]. Taking together, all
these data suggest that inactivation of eIF4G by caspase-3 is not
involved in ASFV-induced shut-off of host protein synthesis. In
fact, we have found that eIF4G is phosphorylated at Ser1108,
indicating that ASFV mRNAs most likely utilize this factor for
Figure 9. P ribosomal protein and mitochondrial network co-localize surrounding ASFV factories. A) Vero cells were seeded on glass
coverslips and infected with 5 pfu/cell of ASFV. For mitochondrial staining, cells were incubated at 15 hpi with 2 mM MitoTracker red CMH2-Ros for
45 min and then permeabilized and fixed. Ribosomal P protein was detected by indirect immunofluorescence and cell nuclei and viral factories were
stained with To-Pro-3. Cells were visualized by confocal microscopy and the cell outline was defined by phase contrast microscopy. Images were
obtained under restricted conditions and processed with Huygens 3.0 software. B) Detection by electron microscopy of ribosomes in mitochondria-
containing areas. Cells were mock infected or infected with 5 pfu/cell of ASFV and processed for electron microscopy at 16 hpi. Ribosomes were
detected using a specific monoclonal antibody against P ribosomal protein.
doi:10.1371/journal.ppat.1000562.g009
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their translation. Moreover, knock down of eIF4GI in COS-7 and
Vero cells diminishes viral protein synthesis and virus spread.
eIF4E is known to be phosphorylated at Ser209 by Mnk-1,
although the real function of this posttranslational modification is
still controversial [9,55]. Nevertheless, a number of viruses, such as
vesicular stomatitis virus or AdV induce the dephosphorylation of
eIF4E, correlating with the shut-off of cellular protein synthesis
[12,13]. In contrast, HSV-1, HCMV and VV infection trigger the
phosphorylation of this initiation factor, which is concomitant with
an increased association between eIF4G and eIF4E [16,17,19].
Mnk-1 activity plays a central role in this process, since inhibition
of this protein with CGP57380 strongly reduces HSV-1 protein
synthesis and virus spread, especially when low virus multiplicities
were used [17]. Furthermore, inhibition of protein kinase p38 also
decreased HSV-1 production, thus indicating that this kinase
phosphorylates Mnk-1 in HSV-1 infected cells [17]. In addition,
Erk kinase may be able to phosphorylate Mnk-1 in VV-infected
cells [16]. In contrast, AdV 100K polypeptide interacts with
eIF4G, thereby overlapping the Mnk-1-binding site and displacing
Mnk-1 from eIF4G [13]. Mnk-1 could therefore be a key target for
translational control by DNA-viruses. We show here that Mnk-1 is
strongly phosphorylated at the late phase of ASFV infection,
correlating with the hyperphosphorylation of eIF4E at Ser209.
The inhibition of Mnk1 by CGP57380 and the subsequent
dephosphorylation of eIF4E induce the increase of the association
of 4E-BP1 with eIF4E from 8 hpi. This might be the cause of the
reduction of eIF4GI binding to m7GTP matrix observed mainly at
16 hpi. Prevention of eIF4E phosphorylation using the Mnk-1
inhibitor CGP57380, inhibits ASFV protein synthesis and virus
production. Thus, we are tempting to speculate that Mnk1
inhibition probably affects to events on the virus lifecycle or to
viral factors regulating 4E-BP, rather than to a general mechanism
linking inhibition of eIF4E phosphorylation with 4E-BP binding.
Thus, Mnk-1 seems also to play an important role in ASFV
infection, although further experiments might be carried out to
further address this point. On the other hand, eIF4GI becomes
hyperphosphorylated at Ser1108 early after ASFV infection
(4 hpi), correlating with a significant increase on eIF4E and
eIF4GI interaction. It is noteworthy that 4E-BP1 is hyperpho-
sphorylated early after ASFV infection, concomitantly with this
strong enhancement on eIF4F assembly. However, 4E-BP1
switches to a hypophosphorylated status after 14 hpi. This event
might be explained as a viral mechanism to stop viral protein
synthesis, when accumulation of structural proteins is sufficient to
ensure viral progeny formation. Interestingly, both phosphoryla-
tion of eIF4GI at Ser1108 as well as hyperphosphorylation of 4E-
BP1, are important but not essential events for ASFV infection of
Vero cells, since the inhibition of mTOR by rapamycin only
affects moderately viral protein synthesis and virus spread,
although eIF4F assembly is inhibited under these conditions.
Nevertheless, it can be speculated that changes in the phosphor-
ylation status of eIF4GI, eIF4E and 4E-BPs could play a more
relevant role on ASFV protein synthesis during the infection of
swine macrophages, the natural target of the virus, since the basal
levels and activity of initiation factors have been shown to be lower
in differentiated cells [56].
On the other hand, our findings support the concept that cap-
dependent translation is strongly stimulated after ASFV infection.
The essential role of eIF4F for ASFV protein synthesis was further
addressed by depletion of eIF4E, eIF4GI or eIF4GII mRNAs with
specific siRNAs. Transfection of eIF4E and eIF4G siRNAs led to a
significant reduction of ASFV protein synthesis, as well as virus
spread. These results indicate that ASFV infection is avoided by
down regulation of these translation initiation factors. Not only
that, but also, it is interesting to note that eIF4E as well as eIF4GI
were redistributed in ASFV-infected cells to localize within viral
replicative sites at 8 hpi, while at late times of the infection, these
factors were displaced to the periphery of viral factories. These
findings point to the exciting idea that ASFV activates and recruits
eIF4F to areas where active viral translation takes place. Such a
mechanism would decrease the availability of eIF4E and eIF4G
for cellular mRNA translation and may contribute to host
translation shut-off. Notably, eIF4E and eIF4GI phosphorylation
and redistribution are elicited during the late phase of ASFV
infection, since AraC prevents all these effects. Mobilization of
eIF4E and eIF4GI requires the synthesis of ASFV late proteins
and, perhaps, the assembly of viral factories, given that
cycloheximide added at 4 hpi but not at 7 hpi prevents this
process.
eIF2a is a key target for antiviral response since regulation of
this initiation factor by phosphorylation provides a rapid and
reversible mechanism to regulate cellular and viral protein
synthesis [3]. In fact, PERK, GCN2 and above all PKR,
phosphorylate eIF2a in response to viral replication and RE stress
induced by viral infection [41–43]. Notably, our present findings
indicate that eIF2a remains unphosphorylated upon ASFV
infection, suggesting the existence of a mechanism to avoid this
antiviral process. ASFV DP71L protein has been shown to bind
the catalytic subunit of protein phosphatase 1 (PP1), leading to
PP1 activation and, consequently, eIF2a dephosphorylation [57].
Thus, DP71L has the ability to prevent the inactivation of eIF2a
by a rapid dephosphorylation of this factor. However, deletion of
the long form of this gene from the genome of the virulent ASFV-
Malawi LIL 20/1 isolate had no effect on virulence [57], hence
suggesting that the virus might further encode genes which
compensate for the loss of the DP71L gene. Therefore, it is likely
that additional viral mechanisms exist that target eIF2a kinases, as
reported for VV K3L protein [3].
It is noteworthy that polyadenylated mRNAs progressively
disappeared from the cytoplasm as ASFV infection progressed.
Cellular polyadenylated mRNAs are probably degraded upon
ASFV infection, consistent with the findings reported for VV-
infected cells [51]. Cellular mRNAs disappeared in parallel with
the inhibition of cellular protein synthesis, suggesting that this
blockade might be, at least in part, a consequence of degradation
of cellular mRNAs in ASFV-infected cells. In this regard, VV
encodes two decapping enzymes, known as D10 and D9, which
cleave the cap structure present at the 59 end of cellular and VV
mRNAs, triggering their degradation by the host machinery
[58,59]. Both VV enzymes contain a nudix domain as in cellular
decapping enzymes [60]. Apparently, these enzymes do not
discriminate between cellular and viral mRNAs in cell free systems
[51,58,59]. Since VV mRNAs are compartmentalized in viral
factories, they would be not available for D10 and D9 enzymatic
degradation because both proteins appear spread in the cytoplasm.
Alternatively, partial degradation of VV mRNAs may be
compensated by their continuous de novo synthesis. Notably, the
ASFV g5R polypeptide also contains a nudix domain [60],
rendering it a good candidate for triggering mRNA decapping and
subsequent degradation in ASFV-infected cells. Further studies in
this new direction will be pursued with the aim of determining the
functional role of g5R during ASFV infection. Furthermore,
poly(A) mRNAs have been detected at the periphery of ASFV
factories. Since we show here that ASFV A224L and p72 mRNAs
also localize at these specific sites, the pool of polyadenylated
mRNAs should correspond to viral mRNAs. Therefore, viral
protein synthesis should take place in close proximity to ASFV-
replicating sites.
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Mobilization of eIF4E and eIF4G to viral factories has been
described for VV-infected cells [16,49]. Our present evidence
indicates that not only eIF4E and eIF4G but also other initiation
and elongation factors, such as eIF3, eIF2 and eEF2 and
ribosomes, are recruited to ASFV factories. Taking into account
that ASFV mRNAs locate at the ASFV-replicating sites, as occurs
with the components of translation machinery, it is likely that viral
translation should take place at these foci, supporting the idea that
replication, transcription, translation and morphogenesis occur in
close proximity in cytoplasmic areas coincident with ASFV viral
factories. Thus, all these processes are tightly coupled, taking place
in discrete cytoplasmic areas to maximize their efficiency.
Interestingly, the mitochondrial network also appears to be
restricted to these areas, partially overlapping with ribosomes.
This novel and interesting observation could reflect the fact that
ATP synthesis is also coupled to viral replication, protein synthesis
and assembly. Coupling between replication, transcription and
translation has been suggested for several RNA viruses [61–64].
Hence, in ASFV-infected cells, the proximity of the different
biosynthetic machineries might help link these three events.
In summary, ASFV stimulates cap-dependent translation to
increase the initiation of viral mRNA translation by activating the
eIF4F complex. In order to favour viral gene expression, the
protein synthesizing machinery and mitochondria are compart-
mentalized within viral factories. Further understanding of the
mechanisms employed by ASFV to recruit these cellular
components to viral replicative foci will provide additional insight
into how ASFV interferes with host translation and optimizes viral
gene expression.
Supporting Information
Figure S1 Redistribution of eIF4GI and eIF4E to the ASFV
factories is blocked by AraC treatment. Vero cells were seeded on
glass coverslips and mock infected or infected with 5 pfu/cell of
ASFV in presence or absence of AraC (40 mg/ml). At 16 hpi cells
were permeabilized, fixed and indirect immunofluorescence was
carried out employing specific antibodies raised against eIF4GI (A)
or eIF4E (B) and ASFV p72. Cells were visualized by confocal
microscopy and the cell outline was defined by phase contrast
microscopy.
Found at: doi:10.1371/journal.ppat.1000562.s001 (2.52 MB PDF)
Figure S2 ASFV late proteins synthesis is required for the
redistribution of eIF4GI and eIF4E to viral factories. Vero cells
were seeded on glass coverslips and mock infected or infected with
5 pfu/cell of ASFV. At 4 or 7 hpi, CHX (10 mg/ml), was added to
the culture medium and cells were fixed and permeabilized at
8 hpi. eIF4GI (A) or eIF4E (B) and ASFV p72 were detected by
indirect immunofluorescence, while cell nuclei and ASFV factories
were stained with To-Pro-3. Cells were visualized by confocal
microscopy and cell outline were defined by phase contrast
microscopy. CHX, cycloheximide.
Found at: doi:10.1371/journal.ppat.1000562.s002 (5.99 MB PDF)
Figure S3 eIF3b, eIF2a and eEF2 are clustered at the periphery
of ASFV factories. Vero cells were seeded on glass coverslips and
mock infected or infected with 5 pfu/cell of ASFV. At 16 hpi cells
were permeabilized and fixed. Translation factors eIF3b (A),
eIF2a (B) or eEF2 (C) were detected simultaneously to and ASFV
p72 by indirect immunofluorescence with specific antisera, while
cellular nuclei and viral factories were stained with To-Pro-3. Cells
were then visualized by confocal microscopy and the cell outline
was defined by phase contrast microscopy. Images were obtained
under restricted conditions.
Found at: doi:10.1371/journal.ppat.1000562.s003 (2.99 MB PDF)
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